BCL2 and acute myeloid leukemia: However, although using an AML mouse model based on transplantation of transduced bone marrow cells into irradiated recipient hosts similar to this study, Luo et al. [11] reported that BCL-2 did not accelerate MYC-induced AML, but rather stimulated development of pre-B acute lymphoid leukemia (ALL).